Skip to main content
. 2021 Jan 2;22(1):410. doi: 10.3390/ijms22010410
AD Alzheimer’s disease
ALS Amyotrophic lateral sclerosis
ASD Autism spectrum disorders
ATP5A ATP synthase alpha-subunit
ATPB ATP synthase beta-subunit
CD9 Cluster of Differentiation 9
CD81 Cluster of Differentiation 81
COX Cytochrome c oxidase subunit
ΔΔCT Delta cycle threshold
DIV Days in vitro
EVs Extracellular vesicles
FMRP Fragile X mental retardation protein
Fmr1 KO Fmr1 knockout (Fmr1-/y)
FXS Fragile X syndrome
GFAP Glial fibrillary acidic protein
JC-1 Tetraethyl benzimidazolyl carbocyanine iodide
LC/MS Liquid chromatography-mass spectrometry
MMP Mitochondrial membrane potential
MT-CO1 COX subunit I encoded by mitochondrial DNA
mtTFA Mitochondrial transcription factor A
NTA Nanoparticle tracking analysis
NRF-1 Nuclear factor, erythroid derived 2, like 1
NRF-2 Nuclear factor, erythroid derived 2, like 2
P2 Postnatal days 2
PBS Phosphate buffered saline
PD Parkinson’s disease
PINK1 PTEN-induced kinase 1
RPLP0 Nuclear gene ribosomal protein large p0
TEM Transmission electron microscopy
VDAC1 Voltage-dependent anion-selective channel 1
VIF Vimentin intermediate filament
WT Wild-type (Fmr1+/y)